Drug trial aims to shrink Pre-Cancerous breast cells before surgery
NCT ID NCT03535506
Summary
This study tested if giving a drug called palbociclib before surgery could reduce abnormal cells in patients with DCIS, a non-invasive, early form of breast cancer. One group of patients received the drug for a short period before their standard surgery, while another group did not. The main goal was to see if this approach was practical and if the drug caused measurable changes in the breast tissue.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DCIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MedStar Georgetown University Hospital
Washington D.C., District of Columbia, 20007, United States
-
Medstar Washington Hospital Center
Washington D.C., District of Columbia, 20010, United States
Conditions
Explore the condition pages connected to this study.